Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear.

A simple test can forecast dementia risk in women as much as 25 years ahead of symptoms emerging, it has been found. Scientists says the findings could help change the way people are treated before ...

A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, researchers say. Experts in the US found that higher levels of a protein called p-tau217 – which is linked ...

Alzheimer’s disease remains a frustratingly difficult condition to manage for the millions of patients affected worldwide and their families. The cause of the disease is still not properly ...

A simple test can forecast dementia risk in women as much as 25 years ahead of symptoms emerging, it has been found. Scientists says the findings could help change the way people are treated before ...

Dementia can be predicted in women up to 25 years before symptoms begin through a simple blood test, according to new research. A protein measured in blood samples is "strongly linked" to the future ...

Lingering inflammation from viruses like COVID-19 or HIV can take a lasting toll on the brain. New research shows exactly how specific immune system imbalances lead to memory lapses and slowed ...

A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, new research suggests. In a new study, a team of researchers in the US found that higher levels of a ...

Scientists have developed a blood test that can predict a woman's risk of developing dementia 25 years before symptom onset, in an effort to revolutionise dementia care.

Scientists have developed a new blood test that could spot Alzheimer’s earlier by detecting hidden changes in how proteins fold in the bloodstream.

Increasing our level of physical fitness leads to a bigger release of brain-boosting proteins following one session of exercise, a new study led by a UCL researcher has found.

Lykke Vestergaard Kastbjerg, 42, and her father Niels, 73, are among hundreds travelling to the UK for treatment.